Preoperative erlotinib in clinical stage I and II non-small cell lung cancer

Autor:	Paul C. Lee, Jeffrey L. Port, Cathy F. Spinelli, David F. Yankelevitz, Nasser K. Altorki
Rok vydání:	2010
Předmět:	Oncology Cancer Research medicine.medical_specialty integumentary system business.industry medicine.disease respiratory tract diseases Epidermal growth factor Internal medicine Medicine Non small cell Erlotinib business Lung cancer medicine.drug
Zdroj:	Journal of Clinical Oncology. 28:e13639-e13639
ISSN:	1527-7755 0732-183X
DOI:	10.1200/jco.2010.28.15_suppl.e13639
Popis:	e13639 Background: Epidermal growth factor TKI inhibitors have demonstrable efficacy in the treatment of advanced non- small cell lung cancer (NSCLC). Little is known about their role in early-stag...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::018e4ea31ee65c18a90156afe2645a5c https://doi.org/10.1200/jco.2010.28.15_suppl.e13639 Zobrazit plný text záznamu